Description

Monoethyl phthalate-d4 is the deuterium labeled Monoethyl phthalate[1]. Monoethyl phthalate is a metabolite of diethyl phthalate. Monoethyl phthalate acts as a urinary biomarker of phthalates exposure indicating the risks of thyroid cancer and benign nodule[2][3].–20°C, 3 years; 4°C, 2 years (Powder)-Applications-Cancer-programmed cell death-Formula-C10H6D4O4-Citation–References-[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]Chong Liu, et al. Urinary biomarkers of phthalates exposure and risks of thyroid cancer and benign nodule. J Hazard Mater. 2020 Feb 5;383:121189.|[3]Celal Güven, et al. Low dose monoethyl phthalate (MEP) exposure triggers proliferation by activating PDX-1 at 1.1B4 human pancreatic beta cells. Food Chem Toxicol. 2016 Jul;93:41-50.-CASNumber-1219806-03-7-MolecularWeight-198.21-Compound Purity-98.27-SMILES-CCOC(C1=C(C([2H])=C([2H])C([2H])=C1[2H])C(O)=O)=O-Research_Area-Cancer-Solubility-DMSO : 50 mg/mL (ultrasonic)-Target-Isotope-Labeled Compounds-Isoform–Pathway-Others-MCE Product type-Isotope-Labeled Compounds